Of patients with no draining tunnels at baseline, 87.8% still had none at one year, and 90.8% at three years* – indicating sustained symptom relief in these lesions Clinically meaningful improvements ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that the ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to pr ...

Q3 2025 Earnings Call Transcript October 30, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.75 ...

On Saturday, Sept. 16, 2023, Sam Terblanche, a junior at Columbia University, went to a soccer match at Yankee Stadium. On ...

How does the brain take out its trash? That is the job of the brain's lymphatic drainage system, and efforts to understand ...

Completed enrollment in Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa; topline data expected mid-2026Appointed Kevin Lind to Board of DirectorsExpanded leadership team ...

“While medical treatments and surgeries are essential, palliative care ensures that no one has to face a life-changing diagnosis alone. It is holistically centred on offering hope, compassion and ...

Following OpenAI’s launch of ChatGPT Atlas, software company Search Atlas flagged a major issue: the AI-powered browser can interact with websites in a way that looks indistinguishable from real human ...